Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP: Kcentra in Trauma
NCT04019015Phase 2Active, not recruiting
- Sponsor
- Oregon Health & Science University
- Start
- Mar 2021
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor X human in hemorrhagic shock, trauma-induced coagulopathy (TIC), sponsored by Oregon Health & Science University. Started Mar 2021; status: active, not recruiting.
02
Drugs
coagulation factor X human
03
Conditions
hemorrhagic shocktrauma-induced coagulopathy (TIC)
Beyond the preview
Go deeper on NCT04019015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04019015.